Avibactam is a non--lactam -lactamase inhibitor antibiotic, which is a new drug application for avibactam in combination with ceftazidime, and was approved by the FDA on February 25, 2015, for treating complicated urinary tract and complicated intra-abdominal Infections caused by antibiotic resistant-pathogens, including those caused by multi-drug resistant gram-negative bacterial pathogens.
仅供研究使用。 我们不向患者出售。
化学信息
名称 | Avibactam sodium |
Iupac 化学名称 | Avibactam sodium |
同义词 | NXL104; NXL-104; NXL 104; Avibactam |
英文同义词 | NXL104; NXL-104; NXL 104; Avibactam |
分子式 | C7H10N3NaO6S |
分子量 | 287.22 |
Smile | S(=O)(=O)(ON1[C@@H]2CCC(N(C1=O)C2)C(N)=O)[O-].[Na+] |
InChiKey | RTCIKUMODPANKX-FVYOBFAJSA-M |
InChi | InChI=1S/C7H11N3O6S.Na/c8-6(11)5-2-1-4-3-9(5)7(12)10(4)16-17(13,14)15;/h4-5H,1-3H2,(H2,8,11)(H,13,14,15);/q;+1/p-1/t4-,5?;/m1./s1 |
Cas号 | 1192491-61-4 |
相关CAS号 | |
外观性状 | crystalline solid |
纯度 | 98% |
存储 | 3 years -20ºCpowder |
可溶性 | Soluble in DMSO |
处理方式 | |
运输条件 | Shipped under ambient temperature as non-hazardous chemical. |
海关编码 | |
Targets | |
Mechanism | |
Cell study | |
Animal study | |
Clinical study | |